JP2018519853A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018519853A5 JP2018519853A5 JP2018513926A JP2018513926A JP2018519853A5 JP 2018519853 A5 JP2018519853 A5 JP 2018519853A5 JP 2018513926 A JP2018513926 A JP 2018513926A JP 2018513926 A JP2018513926 A JP 2018513926A JP 2018519853 A5 JP2018519853 A5 JP 2018519853A5
- Authority
- JP
- Japan
- Prior art keywords
- plant
- thca
- content
- synthetase
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000196324 Embryophyta Species 0.000 claims 16
- 102000003960 Ligases Human genes 0.000 claims 16
- 108090000364 Ligases Proteins 0.000 claims 16
- 102000004533 Endonucleases Human genes 0.000 claims 10
- 108010042407 Endonucleases Proteins 0.000 claims 10
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N Cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 9
- 229950011318 Cannabidiol Drugs 0.000 claims 9
- QHMBSVQNZZTUGM-MSOLQXFVSA-N Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-MSOLQXFVSA-N 0.000 claims 9
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 7
- 229920000023 polynucleotide Polymers 0.000 claims 7
- 239000002157 polynucleotide Substances 0.000 claims 7
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 6
- 229960004242 dronabinol Drugs 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 5
- 230000002222 downregulating Effects 0.000 claims 4
- CYQFCXCEBYINGO-ZYMOGRSISA-N (6aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-ZYMOGRSISA-N 0.000 claims 3
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 3
- 240000005337 Agave sisalana Species 0.000 claims 3
- 235000011624 Agave sisalana Nutrition 0.000 claims 3
- 108020005544 Antisense RNA Proteins 0.000 claims 3
- 229920002391 Guide RNA Polymers 0.000 claims 3
- 108020005004 Guide RNA Proteins 0.000 claims 3
- 108020004459 Small Interfering RNA Proteins 0.000 claims 3
- UCONUSSAWGCZMV-HZPDHXFCSA-N Tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 claims 3
- 229920002847 antisense RNA Polymers 0.000 claims 3
- 230000002759 chromosomal Effects 0.000 claims 3
- 230000000295 complement Effects 0.000 claims 3
- 239000003184 complementary RNA Substances 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 239000002924 silencing RNA Substances 0.000 claims 3
- 108010077850 Nuclear Localization Signals Proteins 0.000 claims 2
- 101700000807 THCAS Proteins 0.000 claims 2
- 229930003827 cannabinoid Natural products 0.000 claims 2
- 239000003557 cannabinoid Substances 0.000 claims 2
- 230000002149 cannabinoid Effects 0.000 claims 2
- 229940065144 cannabinoids Drugs 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 238000006011 modification reaction Methods 0.000 claims 2
- 230000035897 transcription Effects 0.000 claims 2
- VITZNDKHSIWPSR-HZPDHXFCSA-N (6aR,10aR)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-4-carboxylic acid Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=C(C(O)=O)C(CCCCC)=CC(O)=C3[C@@H]21 VITZNDKHSIWPSR-HZPDHXFCSA-N 0.000 claims 1
- 230000033616 DNA repair Effects 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 1
- 229940098465 Tincture Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 claims 1
- 230000003247 decreasing Effects 0.000 claims 1
- 230000003828 downregulation Effects 0.000 claims 1
- 230000002068 genetic Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 230000002829 reduced Effects 0.000 claims 1
- 230000001105 regulatory Effects 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 230000001052 transient Effects 0.000 claims 1
Claims (12)
(a)配列番号61、63、64、69、71、72、68およびそれらの相補体からなる群から選択される配列と、少なくとも85%の配列同一性を有する、ポリヌクレオチド配列;
(b)配列番号61、63、64、69、71、72、68およびそれらの相補体からなる群から選択される配列の、少なくとも21個の連続するヌクレオチドを含む、ポリヌクレオチド配列;もしくは、
(c)THCA合成酵素の、少なくとも21個の連続するヌクレオチドまたはその相補体を含むポリヌクレオチド配列であって、THCA合成酵素が、配列番号1〜47からなる群から選択される配列と、少なくとも85%の配列同一性を有する、ポリヌクレオチド配列によってコードされている;または
(ii)アンチセンスRNAが、
(a)配列番号81またはTHCA合成酵素の発現を減少できるそのフラグメントを含むポリヌクレオチド配列;もしくは
(b)配列番号81の少なくとも200個の連続するヌクレオチドと少なくとも85%同一であるポリヌクレオチド配列によってコードされている;および
選択されたDNAの転写がTHCA合成酵素の発現を抑制する、請求項3記載の方法。 (I) siRNA is
(A) a polynucleotide sequence having at least 85% sequence identity with a sequence selected from the group consisting of SEQ ID NOs: 61, 63, 64, 69, 71, 72, 68 and their complements;
(B) a polynucleotide sequence comprising at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NOs: 61, 63, 64, 69, 71, 72, 68 and their complements; or
(C) the THCA synthase, a polynucleotide sequence comprising a nucleotide, or the complement thereof to at least 21 consecutive, the sequence THCA synthase is selected from the group consisting of SEQ ID NO: 1-47, at least having 85% sequence identity, and is thus encoded by the polynucleotide sequence; or
(Ii) an antisense RNA,
(A) a polynucleotide sequence comprising SEQ ID NO: 81 or a fragment thereof capable of reducing the expression of THCA synthetase; or
(B) encoded by a polynucleotide sequence at least 85% identical to at least 200 contiguous nucleotides of SEQ ID NO: 81; and
4. The method of claim 3, wherein transcription of the selected DNA suppresses expression of THCA synthetase .
(a)アサ植物またはその細胞に、(i)少なくとも1つの核局在シグナルを含む少なくとも1つのRNA誘導型エンドヌクレアーゼ、または少なくとも1つの核局在シグナルを含む少なくとも1つのRNA誘導型エンドヌクレアーゼをコードする核酸、および(ii)少なくとも1つのガイドRNA、または少なくとも1つのガイドRNAをコードするDNAを導入すること;および、
(b)アサ植物またはその細胞を、各ガイドRNAが、RNA誘導型エンドヌクレアーゼを染色体配列における標的部位に誘導するように、培養し、そこでRNA誘導型エンドヌクレアーゼは標的部位に二本鎖切断を導入し、二本鎖切断は、染色体配列を改変するように、DNA修復過程によって修復され、ここで標的部位がTHCA合成酵素の遺伝子に位置し、染色体の改変がTHCA合成酵素の遺伝子の転写および/または翻訳を妨げ、または阻害すること、
を含む、請求項1記載の方法。 Down-regulating the activity of THCA synthetase
(A) Asa plant or cells thereof (i) at least one RNA-inducible endonuclease comprising at least one nuclear localization signal, or at least one RNA-inducing endonuclease comprising at least one nuclear localization signal nucleic acid encoding, and (ii) at least one guide RNA or introducing DN a encoding at least one guide RNA,; and,
(B) Assassins or their cells are cultured such that each guide RNA directs the RNA inducible endonuclease to the target site in the chromosomal sequence, where the RNA inducible endonuclease cleaves a double strand at the target site The introduced double-strand break is repaired by a DNA repair process so as to alter the chromosomal sequence, where the target site is located in the THCA synthetase gene, the chromosomal alteration is the THCA synthetase gene transcription and And / or preventing or inhibiting translation,
The method of claim 1, comprising:
(ii)THCA合成酵素の活性を下方制御することが外来性遺伝物質を挿入せず、天然に存在しないアサ植物またはその細胞を作成する、請求項5または6に記載の方法。 (I) The RNA-inducible endonuclease is from a clustered equally-spaced short batch repeat (Prisins) / Pensor related (Cas) system ; or
(Ii) The method according to claim 5 or 6, wherein down-regulating the activity of THCA synthetase does not insert foreign genetic material, thereby producing a non-naturally occurring plant or cell thereof .
(a)アサ植物またはその細胞のDNA配列において、少なくとも1つのTHCA合成酵素の遺伝子座を同定すること;
(b)少なくとも1つのTHCA合成酵素の遺伝子座において、少なくとも1つのカスタムエンドヌクレアーゼ認識配列を同定すること;
(c)アサ植物またはその細胞に、少なくとも第一のカスタムエンドヌクレアーゼを導入し、ここでアサ植物またはその細胞が、カスタムエンドヌクレアーゼの認識配列を、THCA合成酵素の遺伝子座内またはその近位に含み、カスタムエンドヌクレアーゼが一過性または安定に発現されること;
(d)アサ植物またはその細胞を、THCA合成酵素の遺伝子座を構成するDNAまたはそれに隣接するDNAにおける、カスタムエンドヌクレアーゼを介する改変について、アッセイすること;および、
(e)アサ植物、その細胞またはその子孫細胞を、THCA合成酵素の遺伝子座に改変を含むものとして同定すること、
を含む、請求項1記載の方法。 Down-regulating the activity of THCA synthetase
(A) identifying the locus of at least one THCA synthetase in the DNA sequence of the assassin plant or its cells;
(B) identifying at least one custom endonuclease recognition sequence at a locus of at least one THCA synthetase;
(C) At least a first custom endonuclease is introduced into the assassin plant or cells thereof, wherein the assassin plant or cells thereof recognize the custom endonuclease site within or near the locus of THCA synthetase Containing and transient or stable expression of custom endonucleases;
(D) assaying the Asa plant or cells thereof for custom endonuclease-mediated modification in the DNA constituting the THCA synthetase locus or in the DNA adjacent thereto;
(E) identifying an Asa plant, its cells or their progeny as containing a modification at the THCA synthetase locus;
The method of claim 1, comprising:
(a)総重量で約18%〜約60%または約7%〜約30%の濃度のカンナビジオール酸およびカンナビジオール; (A) cannabidiol acid and cannabidiol at a concentration of about 18% to about 60% or about 7% to about 30% by total weight;
(b)総重量で約0%〜約3%の濃度のデルタ−9−テトラヒドロカンナビノールおよびテトラヒドロカンナビノール酸;または (B) Delta-9-tetrahydrocannabinol and tetrahydrocannabonic acid at a concentration of about 0% to about 3% by total weight; or
(c)アサの油、アサのチンキ、乾燥したアサの花および/または乾燥したアサの葉。 (C) Asa oil, asa tincture, dried asa flower and / or dried asa leaf.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562167462P | 2015-05-28 | 2015-05-28 | |
US62/167,462 | 2015-05-28 | ||
PCT/IB2016/000814 WO2016189384A1 (en) | 2015-05-28 | 2016-05-27 | Cannabis plants having modified expression of thca synthase |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018519853A JP2018519853A (en) | 2018-07-26 |
JP2018519853A5 true JP2018519853A5 (en) | 2019-06-27 |
Family
ID=57393331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018513926A Pending JP2018519853A (en) | 2015-05-28 | 2016-05-27 | Asa plant with modified expression of THCA synthase |
Country Status (14)
Country | Link |
---|---|
US (2) | US10934554B2 (en) |
EP (1) | EP3302033A4 (en) |
JP (1) | JP2018519853A (en) |
KR (1) | KR20180021718A (en) |
CN (1) | CN107846861A (en) |
AU (1) | AU2016269328A1 (en) |
BR (1) | BR112017025388A2 (en) |
CA (1) | CA2986666A1 (en) |
CL (1) | CL2017002998A1 (en) |
HK (1) | HK1252151A1 (en) |
IL (2) | IL255900B (en) |
MX (1) | MX2017015304A (en) |
RU (1) | RU2017146186A (en) |
WO (1) | WO2016189384A1 (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180021718A (en) * | 2015-05-28 | 2018-03-05 | 트위드 인크. | Cannabis plants with modified expression of THCA synthase |
AU2016275186A1 (en) * | 2015-06-12 | 2018-02-01 | Anandia Laboratories Inc. | Methods and compositions for cannabis characterization |
PE20190654A1 (en) * | 2016-08-18 | 2019-05-08 | Canopy Growth Corp | PLANTS AND METHODS TO INCREASE AND DECREASE CANNABINOID SYNTHESIS |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
CN106591359B (en) * | 2017-02-13 | 2019-10-25 | 黑龙江省科学院大庆分院 | A kind of construction method of hemp THCA synthase gene RNAi carrier |
WO2018176055A2 (en) | 2017-03-24 | 2018-09-27 | Trait Biosciences, Inc. | High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems |
WO2019070876A2 (en) * | 2017-10-03 | 2019-04-11 | The Regents Of The University Of Colorado | Method for differentiating cannabis plant cultivars based on cannabinoid synthase paralogs |
GB2568032B (en) | 2017-10-25 | 2023-03-15 | Cell Science Holdings Ltd | A method of production of phytocannabinoids for use in medical treatments |
US20200347394A1 (en) * | 2017-11-02 | 2020-11-05 | Yield10 Bioscience, Inc. | Genes and gene combinations for enhanced crops |
CA3123182A1 (en) * | 2017-12-14 | 2019-06-20 | Medicinal Genomics Corporation | Methods and kits for classifying cannabinoid production in cannabis plants |
US11202771B2 (en) | 2018-01-31 | 2021-12-21 | Treehouse Biotech, Inc. | Hemp powder |
CN112040942A (en) * | 2018-02-20 | 2020-12-04 | 苏佩拉制药公司 | Genetically modified cannabis plants and modified cannabinoid compounds for use in treating substance addiction and other disorders |
US20230110830A1 (en) | 2018-04-09 | 2023-04-13 | Ellevet Sciences | Hemp extract for treatment of pain in animals |
CN112424365A (en) | 2018-06-07 | 2021-02-26 | 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 | Nucleic acid constructs and methods of use thereof |
US10897925B2 (en) * | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
CA3105433C (en) * | 2018-08-17 | 2023-07-11 | Canbreed Ltd. | Cannabis plant cells with reduced delta-9-tetrahydrocannabinol (thc) content |
CN109122306A (en) * | 2018-08-20 | 2019-01-04 | 杭州昶胜电子商务有限公司 | A method of obtaining high cannabidiol content industrial hemp plant |
EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | Synthesis of cannabigerol |
EP3876704A4 (en) * | 2018-11-09 | 2022-10-26 | Agriculture Victoria Services Pty Ltd | Cannabis plants with a cannabinoid profile enriched for d-9-tetrahydrocannabinol, cannabigerol and tetrahydrocannabivarin |
US10653085B1 (en) * | 2018-12-21 | 2020-05-19 | Charlotte's Web, Inc. | Hemp plant named ‘CW1AS1’ |
CA3130763A1 (en) | 2019-02-25 | 2020-09-03 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
WO2020183352A1 (en) * | 2019-03-12 | 2020-09-17 | Radient Technologies Innovations Inc. | Time specific bioavailability of extract in consumable |
SG11202111309RA (en) * | 2019-04-11 | 2021-11-29 | Kah Meng Lim | Process for producing a genetically modified seed |
US20210071186A1 (en) * | 2019-07-17 | 2021-03-11 | Wisconsin Alumni Research Foundation | Methods of gene editing and transforming cannabis |
EP4017516A4 (en) * | 2019-08-23 | 2023-07-12 | Canopy Growth Corporation | Methods for reducing thc content in complex cannabinoid mixtures in which thc is a minor component |
CA3153420A1 (en) * | 2019-09-06 | 2021-03-11 | James Berman | Genetic modification of plants |
CN110419397A (en) * | 2019-09-06 | 2019-11-08 | 黑龙江汉美生工业大麻科技有限公司 | A kind of Cultivate administration method improving No. 5 CBD contents of imperial hemp |
IL291837A (en) * | 2019-10-01 | 2022-06-01 | Empyrean Neuroscience Inc | Genetically modified plants and methods of making the same |
CA3152875A1 (en) * | 2019-10-01 | 2021-04-08 | Thomas Henley | Genetically modified plants and methods of making the same |
KR20220079578A (en) * | 2019-10-11 | 2022-06-13 | 내셔널 유니버시티 오브 싱가포르 | Biosynthesis of cannabinoids from cannabigerolic acid using novel cannabinoid synthase |
CN110923242B (en) * | 2019-12-14 | 2021-04-13 | 厦门梓蔓生物科技有限公司 | Transcription factor CsAPL1 separated from hemp glandular hair and application thereof |
EP3841872A1 (en) | 2019-12-28 | 2021-06-30 | Ploidy and Genomics SL. | In vitro direct regeneration of polyploid cannabis plants |
WO2021138423A1 (en) * | 2019-12-30 | 2021-07-08 | Arcadia Biosciences, Inc. | Methods for genetically modifying cannabis plants, modified cannabis plants, and products therefrom |
CA3175033A1 (en) * | 2020-03-10 | 2021-05-20 | Phylos Bioscience, Inc. | Autoflowering markers |
AU2021307691A1 (en) * | 2020-07-13 | 2023-02-02 | BetterSeeds Ltd. | Cannabis with altered cannabinoid content |
US20230357785A1 (en) * | 2020-09-22 | 2023-11-09 | Growing Together Research Inc. | Genetically modified cannabis plants with novel phenotypes |
WO2023015268A1 (en) * | 2021-08-06 | 2023-02-09 | Phylos Bioscience, Inc. | Varin genes |
AU2022341127A1 (en) * | 2021-09-09 | 2024-04-18 | Agriculture Victoria Services Pty Ltd | Methods for the modification of cells, modified cells and uses thereof |
CN114214339A (en) * | 2021-12-08 | 2022-03-22 | 福建农林大学 | Hemp THCSAS2 gene, terpene phenolic acid oxidative cyclase as coded product thereof and application of terpene phenolic acid oxidative cyclase |
WO2023195781A1 (en) * | 2022-04-05 | 2023-10-12 | 주식회사 진코어 | Composition comprising gene editing protein for cannabis sativa gene editing, and gene editing method using same |
USPP35571P2 (en) | 2023-05-05 | 2024-01-09 | Phat Panda LLC | Cannabis plant named ‘AC/DC x Redneck Wedding 13’ |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003161A1 (en) | 1990-10-22 | 1993-02-18 | Biosource Genetics Corporation | Recombinant plant viral nucleic acids |
ATE367809T1 (en) | 1998-04-21 | 2007-08-15 | Us Health | CANNABINOIDS AS ANTIOXIDANTS AND NEUROPROTECTIVE AGENTS |
US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
AU2002331595A1 (en) | 2001-08-15 | 2003-03-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of | Novel vasoconstrictor cannabinoid analogs |
GB2439393B (en) | 2006-06-23 | 2011-05-11 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
US9035130B2 (en) * | 2007-05-31 | 2015-05-19 | Gw Pharma Limited | Reference plant, a method for its production, extracts obtained therefrom and their use |
GB2450741A (en) | 2007-07-05 | 2009-01-07 | Gw Pharma Ltd | Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease |
GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
US20110257256A1 (en) | 2008-07-31 | 2011-10-20 | Bionoria Research Gmbh | Cannabinoids for use in treating or preventing cognitive impairment and dementia |
US8884100B2 (en) * | 2009-08-12 | 2014-11-11 | National Research Council Of Canada | Aromatic prenyltransferase from Cannabis |
CA2796465C (en) | 2010-04-15 | 2021-10-19 | University Of Saskatchewan | Genes and proteins for aromatic polyketide synthesis |
US20120311744A1 (en) | 2011-06-06 | 2012-12-06 | Erich E. Sirkowski | Marked Cannabis For Indicating Medical Marijuana |
US9546362B2 (en) * | 2011-07-13 | 2017-01-17 | National Research Council Of Canada | Genes and proteins for alkanoyl-CoA synthesis |
WO2014145490A2 (en) * | 2013-03-15 | 2014-09-18 | Biotech Institute, Llc | Breeding, production, processing and use of specialty cannabis |
US10441617B2 (en) * | 2013-03-15 | 2019-10-15 | Biotech Institute, Llc | Breeding, production, processing and use of medical cannabis |
US20150098954A1 (en) | 2013-10-08 | 2015-04-09 | Elwha Llc | Compositions and Methods Related to CRISPR Targeting |
US9546960B2 (en) | 2014-11-14 | 2017-01-17 | Lightwave Science, Inc. | System and method for analysis of cannabis |
KR20180021718A (en) * | 2015-05-28 | 2018-03-05 | 트위드 인크. | Cannabis plants with modified expression of THCA synthase |
-
2016
- 2016-05-27 KR KR1020177036976A patent/KR20180021718A/en unknown
- 2016-05-27 MX MX2017015304A patent/MX2017015304A/en unknown
- 2016-05-27 CN CN201680030407.6A patent/CN107846861A/en active Pending
- 2016-05-27 US US15/577,708 patent/US10934554B2/en active Active
- 2016-05-27 CA CA2986666A patent/CA2986666A1/en active Pending
- 2016-05-27 JP JP2018513926A patent/JP2018519853A/en active Pending
- 2016-05-27 BR BR112017025388-7A patent/BR112017025388A2/en active Search and Examination
- 2016-05-27 RU RU2017146186A patent/RU2017146186A/en not_active Application Discontinuation
- 2016-05-27 EP EP16799427.6A patent/EP3302033A4/en not_active Withdrawn
- 2016-05-27 WO PCT/IB2016/000814 patent/WO2016189384A1/en active Application Filing
- 2016-05-27 AU AU2016269328A patent/AU2016269328A1/en not_active Abandoned
-
2017
- 2017-11-26 IL IL255900A patent/IL255900B/en active IP Right Grant
- 2017-11-27 CL CL2017002998A patent/CL2017002998A1/en unknown
-
2018
- 2018-09-07 HK HK18111542.0A patent/HK1252151A1/en unknown
-
2020
- 2020-12-22 US US17/131,641 patent/US20210207154A1/en not_active Abandoned
-
2021
- 2021-03-15 IL IL281500A patent/IL281500B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018519853A5 (en) | ||
RU2017146186A (en) | KONOPLI PLANTS WITH MODIFIED THCA-SYNTHASE EXPRESSION | |
Ye et al. | Cytoplasmic assembly and selective nuclear import of Arabidopsis Argonaute4/siRNA complexes | |
CA3105433C (en) | Cannabis plant cells with reduced delta-9-tetrahydrocannabinol (thc) content | |
Morita et al. | Tandemly arranged chalcone synthase A genes contribute to the spatially regulated expression of siRNA and the natural bicolor floral phenotype in Petunia hybrida | |
Gao et al. | Characterization and cloning of grape circular RNAs identified the cold resistance-related Vv-circATS1 | |
Liu et al. | Characterization and function of microRNA∗ s in plants | |
Zhang et al. | Over‐expression of sly‐miR156a in tomato results in multiple vegetative and reproductive trait alterations and partial phenocopy of the sft mutant | |
Wu et al. | Genomewide analysis of small RNA s in nonembryogenic and embryogenic tissues of citrus: micro RNA‐and si RNA‐mediated transcript cleavage involved in somatic embryogenesis | |
Sun et al. | Combined small RNA and degradome sequencing reveals complex microRNA regulation of catechin biosynthesis in tea (Camellia sinensis) | |
Zeng et al. | Identification and characterization of miRNAs in ripening fruit of Lycium barbarum L. using high-throughput sequencing | |
Sun et al. | Inhibition of pds gene expression via the RNA interference approach in Dunaliella salina (Chlorophyta) | |
Tang et al. | Identification of microRNAs involved in regeneration of the secondary vascular system in Populus tomentosa Carr | |
CA3131231A1 (en) | Powdery mildew resistant cannabis plants | |
CN104830859B (en) | A kind of tea tree miRNA and its application | |
Xu et al. | Identification and differential regulation of microRNAs in response to methyl jasmonate treatment in Lycoris aurea by deep sequencing | |
Nageshbabu et al. | Expression of miRNAs regulates growth and development of French bean (Phaseolus vulgaris) under salt and drought stress conditions | |
Yin et al. | Involvement of miRNAs-mediated senescence and salicylic acid defense in postharvest litchi downy blight | |
Watanabe | Overview of plant RNAi | |
Feliciano | CXCL1 and CXCL2 link metastasis and chemoresistance | |
Kasai et al. | Molecular mechanism of seed coat discoloration induced by low temperature in yellow soybean | |
Sternes et al. | Deep sequencing reveals divergent expression patterns within the small RNA transcriptomes of cultured and vegetative tissues of sugarcane | |
CN110331143A (en) | For the miRNA and coding nucleic acid molecule of the leaf regulation of sweet potato and application | |
Chen et al. | Production of functional double‐stranded RNA using a prokaryotic expression system in Escherichia coli | |
Diler et al. | Differential expression of hyperhydricity responsive peach microRNAs |